Which Defence Fails First? Minimum-Action Escape from Immune-Mediated Cancer Dormancy in a Non-Gradient Tumour–Immune System
This study investigates the mechanisms underlying escape from immune-mediated cancer dormancy by explicitly modelling the tumour and immune effector populations as a coupled, fluctuating system. Using the classical tumour–effector model of Kuznetsov et al., with experimentally estimated parameters, we apply Freidlin–Wentzell large-deviation theory and the geometric minimum action method to identify the most likely escape pathway. We demonstrate that the system has no potential landscape and that a one-dimensional reduction is not valid across the escape region. The computed minimum-action barrier is ΔU = 0.236, with Monte Carlo simulations supporting the predicted Arrhenius scaling and escape route. The results indicate that immune effector fluctuations account for 88.5% of the escape action under isotropic noise. The most likely escape pathway involves a transient decline in immune effector cells before tumour expansion. Furthermore, as immune stimulation approaches the tipping point, tumour-marker variance increases while immune-marker variance initially decreases. These findings suggest that immune variability plays a major role in cancer dormancy escape, while tumour-marker variance and autocorrelation may provide more reliable early-warning signals of dormancy erosion. The study offers a mathematical and computational framework for understanding tumour–immune escape dynamics and identifying potential monitoring strategies.
Authors
- Kiran Kalyankar
- Sakshi Sharma
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.5281/zenodo.24306032
- Primary Topic
- Mathematical Biology Tumor Growth
- Type
- preprint